title: [Evolution of Escherichia coli resistance in community acquired peritonitis].
authors.forename: H
authors.initials: H
authors.lastname: Nejmi
authors.forename: B
authors.initials: B
authors.lastname: Laghla
authors.forename: M
authors.initials: M
authors.lastname: Boutbaoucht
authors.forename: M A
authors.initials: MA
authors.lastname: Samkaoui
mesh_terms: D000328:Adult; D019980:Amoxicillin-Potassium Clavulanate Combination / Q000494:pharmacology; D001064:Appendicitis / Q000150:complications; D002511:Cephalosporins / Q000627:therapeutic use; D017714:Community-Acquired Infections / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology*; D024901:Drug Resistance, Multiple, Bacterial; D000077727:Ertapenem; D004926:Escherichia coli / Q000187:drug effects / Q000302:isolation & purification*; D004927:Escherichia coli Infections / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology / Q000382:microbiology*; D005260:Female; D006801:Humans; D007422:Intestines / Q000382:microbiology; D008297:Male; D009018:Morocco / Q000453:epidemiology; D010439:Peptic Ulcer Perforation / Q000150:complications; D010538:Peritonitis / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology / Q000382:microbiology*; D017410:Practice Guidelines as Topic; D011446:Prospective Studies; D047090:beta-Lactams / Q000627:therapeutic use
chemical_list: D002511:Cephalosporins; D047090:beta-Lactams; D019980:Amoxicillin-Potassium Clavulanate Combination; D000077727:Ertapenem